Protein marker linked with poor cancer outcomeBMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7077.323a (Published 01 February 1997) Cite this as: BMJ 1997;314:323
- Susan Mayor
There are new hopes of a reliable indicator for the aggressiveness of tumour cells as three independent studies show that low amounts of p27–a protein that inhibits the cell cycle–are associated with poor survival in breast and colorectal carcinoma.
All three studies were reported in this month's Nature Medicine (1997;3:222-5;227-30;231-4). One study of 168 cases of primary breast cancer showed that low nuclear expression of p27 was a significant predictor of poor disease free survival. Researcher Dr Joyce Slingerland, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial